OraSure Technologies Inc

Financials

Overview Estratto Conto Statistics Dividends

Cash from operating activities 5.81 M-35.38 M-47.2 M141.58 M27.37 M -39.92 M Cash from investing activities -14.03 M-5.5 M21.09 M66.15 M-39.03 M -7.88 M Cash from financing activities 92.48 M-2.82 M-3.83 M-3.02 M-4.18 M -11.94 M Free cash flow -20.87 M-72 M-53.98 M135.78 M23.58 M -43.65 M

OraSure Technologies, Inc. is a Bethlehem, Pennsylvania–based company in the medical device industry. Their products include diagnostic testing kits. The company had recently developed OraQuick testing kit, the first over-the-counter home HIV test.

OSUR

Financials

OraSure Technologies Inc

Notizie

OraSure Technologies, Inc. (OSUR) Q4 2025 Earnings Call Transcript

Gli EPS di OraSure sono risultati in linea con le aspettative, il fatturato appena sotto le previsioni

OraSure earnings matched, revenue fell short of estimates

OraSure’s HIV self-test receives Health Canada license

Phibro Animal Health (PAHC) Q2 Earnings and Revenues Surpass Estimates

Altai Capital nomina due amministratori per il consiglio di OraSure Technologies

Altai Capital nominates two directors for OraSure Technologies board

Altai Capital nomina due direttori al consiglio di OraSure tra preoccupazioni

Altai Capital nominates two directors to OraSure board amid concerns

OraSure Files for FDA Review of Molecular Self-Test & Colli-Pee Device

OraSure submits FDA applications for rapid STI test and collection device

NeoGenomics nomina il veterano della diagnostica Jack Kenny nel consiglio